The potential of BRD4 inhibition in tumour mechanosignaling

被引：1
|
作者：
Gargalionis, Antonios N. [1 ]
Papavassiliou, Kostas A. [2 ]
Papavassiliou, Athanasios G. [3 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Eginition Hosp, Med Sch, Dept Biopathol, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Univ Dept Resp Med 1, Sotiria Hosp, Med Sch, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Med Sch, Dept Biol Chem, 75 Mikras Asias St,Bldg 16, Athens 11527, Greece
来源：
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 2023年 / 27卷 / 24期
关键词：
BRD4; mechanosignaling; targeted therapy; TAZ; tumour inhibitor; YAP; YAP/TAZ;
D O I：
10.1111/jcmm.18057
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：4215 / 4218
页数：4
相关论文
共 50 条
  • [31] BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination
    Jung, Hyunkyung
    Chen, Jinjing
    Hu, Xiangming
    Sun, Hao
    Wu, Shwu-Yuan
    Chiang, Cheng-Ming
    Kemper, Byron
    Chen, Lin-Feng
    Kemper, Jongsook Kim
    JCI INSIGHT, 2021, 6 (01)
  • [32] Publisher Correction: BRD4 interacts with NIPBL and BRD4 is mutated in a Cornelia de Lange–like syndrome
    Gabrielle Olley
    Morad Ansari
    Hemant Bengani
    Graeme R. Grimes
    James Rhodes
    Alex von Kriegsheim
    Ana Blatnik
    Fiona J. Stewart
    Emma Wakeling
    Nicola Carroll
    Alison Ross
    Soo-Mi Park
    Wendy A. Bickmore
    Madapura M. Pradeepa
    David R. FitzPatrick
    Nature Genetics, 2018, 50 : 767 - 767
  • [33] Inhibition of BRD4 enhanced the tumor suppression effect of dasatinib in gastric cancer
    Shen, Hao
    Hu, Xuefei
    Yang, Xinrui
    Chen, Jiahui
    Fu, Yating
    He, Hongwei
    Shi, Yongkang
    Zeng, Rong
    Chang, Wenjun
    Zheng, Shangyong
    MEDICAL ONCOLOGY, 2022, 40 (01)
  • [34] Supercharging BRD4 with NUT in carcinoma
    Eagen, Kyle P.
    French, Christopher A.
    ONCOGENE, 2021, 40 (08) : 1396 - 1408
  • [35] CREATING A LASSO TO REIN IN BRD4
    Davis, Mindy I.
    Simeonov, Anton
    Auld, Doug
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2015, 13 (08) : 437 - 443
  • [36] Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
    Liu, Yi
    Liu, Hejing
    Ye, Miaomiao
    Jiang, Mengying
    Chen, Xin
    Song, Gendi
    Ji, Huihui
    Wang, Zhi-wei
    Zhu, Xueqiong
    CELL DEATH & DISEASE, 2023, 14 (09)
  • [37] BRD4 Degradation By Protacs Represents a More Effective Therapeutic Strategy Than BRD4 Inhibitors in DLBCL
    Lu, Jing
    Qian, Yimin
    Raina, Kanak
    Altieri, Martha
    Dong, Hanqing
    Wang, Jing
    Chen, Xin
    Crew, Andrew
    Coleman, Kevin
    Crews, Craig
    Winkler, James
    BLOOD, 2015, 126 (23)
  • [38] Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
    Yi Liu
    Hejing Liu
    Miaomiao Ye
    Mengying Jiang
    Xin Chen
    Gendi Song
    Huihui Ji
    Zhi-wei Wang
    Xueqiong Zhu
    Cell Death & Disease, 14
  • [39] Publisher Correction: BRD4 interacts with NIPBL and BRD4 is mutated in a Cornelia de Lange–like syndrome
    Gabrielle Olley
    Morad Ansari
    Hemant Bengani
    Graeme R. Grimes
    James Rhodes
    Alex von Kriegsheim
    Ana Blatnik
    Fiona J. Stewart
    Emma Wakeling
    Nicola Carroll
    Alison Ross
    Soo-Mi Park
    Wendy A. Bickmore
    Madapura M. Pradeepa
    David R. FitzPatrick
    Nature Genetics, 2019, 51 : 1192 - 1192
  • [40] Adjusted degradation of BRD4 S and BRD4 L based on fine structural modifications of the pyrrolopyridone scaffold
    Chen, Jingjing
    He, Huixin
    Wei, Aihuan
    Li, Yalei
    Cheng, Gang
    Qin, Hui
    Zhong, Hanyue
    Liu, Hongchun
    Geng, Meiyu
    Shen, Aijun
    Hu, Youhong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 236
12345